Abreva Cream
Pricing Report NDC 0135-0200-03

Latest NADAC: $8.11988 per GM · Effective Mar 18, 2020 · Est. package price $16.24 (2 GM)

Current Package Pricing Information

The latest wholesale acquisition cost for Abreva (NDC 0135-0200-03) is $8.11988 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 18, 2020.

As a a human over the counter drug provided by Haleon Us Holdings Llc, this medication is distributed in a 2 g in 1 BOTTLE, PUMP configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$8.11988
Per GM

Effective Date
Mar 18, 2020
Billable Units
2 GM
Estimated Package Price
$16.24
Data Status
As of Jul 01, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
2 g in 1 BOTTLE, PUMP
Generic Benchmark
The generic equivalent rate is $6.41143 (Effective: May 20, 2020)
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $6.88855 to $8.22252 per GM. Over this 6 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$6.8886 - $8.2225
Market Volatility
19.37% Variance
Latest Trend
1.25%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Mar 18, 2020 $8.11988 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Mar 18, 2020 $8.11988 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Mar 18, 2020 $8.11988 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Mar 18, 2020 $8.11988 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Mar 18, 2020 $8.11988 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Mar 18, 2020 $8.11988 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Mar 18, 2020 $8.11988 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Mar 18, 2020 $8.11988 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Mar 18, 2020 $8.11988 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
May 22, 2019 $8.22252 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 22, 2019 $8.22252 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
May 22, 2019 $8.22252 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026